Go Deep
OS Therapies Incorporated
OS Therapies Incorporated Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -20,976 | -1.3 | -5.46 | 0.00 | 131.98 |
| Oct 2026 | -21,060 | -1.4 | -5.54 | 0.00 | 133.90 |
| Oct 2026 | -20,683 | -1.2 | -5.18 | 0.00 | 125.02 |
| Oct 2026 | -20,673 | -1.2 | -4.99 | 0.00 | 120.42 |
| Oct 2026 | -20,631 | -1.2 | -4.95 | 0.00 | 119.47 |
| Oct 2026 | -20,673 | -1.2 | -4.99 | 0.00 | 120.12 |
| Oct 2026 | -20,589 | -1.2 | -4.91 | 0.00 | 117.99 |
OS Therapies Incorporated Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -8,632,386.0 | -10,396,831.0 | -13,460,833.0 | -6,879,530.0 |
| EPS | -0.2 | -0.3 | — | -0.2 |
OS Therapies Incorporated Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -28,753,844.0 | -8,882,938.0 | -7,791,582.0 | -6,254,685.0 | — |
| EPS | -1.0 | -1.3 | -0.4 | -0.3 | — |
OS Therapies Incorporated Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 6,839,534.0 | 5,538,797.0 | 798,082.0 | 509,105.0 | — |
| Total Liabilities | 12,935,165.0 | 8,805,335.0 | 24,814,297.0 | 18,066,333.0 | — |
| Total Equity | -6,095,631.0 | -3,266,538.0 | -24,016,215.0 | -17,557,228.0 | — |
Owes vs Owns
OS Therapies Incorporated owed $2.20 for every $1 it owned in Jun 2026, down from $35.5 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 2.20× | 1.89× | 1.59× | 31.1× | 35.5× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
OS Therapies Incorporated Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 3.9%Intangible assets 95.1%Other assets 0.9%
How it's funded — Dec 2025
Payables 76.8%Other liabilities 23.2%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.3 | 5.5 | 0.0 | 0.2 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 | 0.0 | 0.0 |
| Intangible assets | 6.5 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.1 | 0.0 | 0.8 | 0.3 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 14.6 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 10.3 |
| Payables | 9.9 | 1.7 | 2.7 | 1.2 |
| Other liabilities | 3.0 | 7.1 | 7.5 | 6.5 |
| Shareholders' equity | -6.1 | -3.3 | -24.0 | -17.6 |
| Net tangible assets | -12.6 | -3.3 | -24.0 | -17.6 |
OS Therapies Incorporated Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -14,238,576.0 | -7,282,295.0 | -3,006,967.0 | -3,792,580.0 | — |
| Investing Activities | -466,423.0 | 0.0 | 1,145.0 | 230,881.0 | — |
| Financing Activities | 9,441,302.0 | 12,776,840.0 | 2,873,324.0 | 3,652,391.0 | — |